SYNERGETIC B-CELL IMMUNOMODULATION WITH RITUXIMAB AND BELIMUMAB IS CLINICALLY EFFECTIVE IN SEVERE AND REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS - THE SYNBIOSE PROOF-OF-CONCEPT STUDY
Author(s):
Kraaij, T.; Kamerling, S.W.; Rooij, E. de; Daele, P.L. van; Bajema, I.; Bredewold, O.W.; Huizinga, T.W.; Rabelink, T.J.; Kooten, C. van (0000-0002-6257-0899); Teng, Y.K.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-06-30
Language
English
Is part of
Annals of the Rheumatic Diseases (2017), Vol. 76, p. 871-871
